A Board Member Bought Over $300,000 of Abbott Labs

Page 1 of 2

A member of Abbott Laboratories (NYSE:ABT)’s Board of Directors, William Osborn, recently bought 10,000 shares of stock at prices between $33.80 and $33.90. He now owns a little over 34m000 shares of the stock, so this is a significant purchase in percentage terms. Studies show that insider purchases are bullish signs (see our analysis of studies on insider trading). We think that this is because an insider must be confident enough in the company’s prospects to ignore the benefits of diversification before buying the stock.

Abbott Laboratories is a $53 billion market provider of pharmaceuticals (including generics), diagnostic systems, and medical devices. Last quarter it experienced a 4% increase in revenue compared to the fourth quarter of 2011. With operating expenses up only slightly- thanks in part to a small reduction in R&D- operating income grew 16% from its levels a year earlier. While earnings were down, this was due to a large loss on extinguishment of debt that we think we can assume is in the best interests of Abbott Labs as well as non-recurring.

MILLENNIUM MANAGEMENT

The stock trades at 9 times trailing earnings, though judging from analyst expectations it appears that is based on abnormally high net income in 2012. Consensus is for $2.02 in EPS this year, implying a current-year P/E of 17. We would say that from a value perspective that would be a decent multiple assuming moderate earnings growth over the next several years, and so we could see a value investor doing further research on the stock. While many pharmaceutical companies are thought of as income stocks, Abbott Laboratories is not quite optimal there: the beta is indeed fairly low at 0.5, but the dividend yield is less than 2%.

Billionaire Israel Englander’s Millennium Management increased its stake in Abbott Labs during the third quarter to a total of about 940,000 shares (find Englander’s favorite stocks). Citadel Investment Group, which is managed by billionaire Ken Griffin, reported a position of 1.6 million shares on its own 13F (check out Griffin’s stock picks). Orbimed Advisors, a healthcare focused fund run by Samuel Isaly and his team, was also buying the stock and closed September with 2.5 million shares in its portfolio (research more stocks that Orbimed was buying).

How does Abbott compare to similar companies?

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!